Ascendis Pharma A/S (NASDAQ:ASND) Receives Average Rating of “Moderate Buy” from Brokerages

Zebra Technologies Corporation (NASDAQ:ZBRA) received a consensus rating of Moderate Buy from eleven brokerages, with five hold, five buy, and one strong buy; average 1‑year target $339.25. Ascendis Pharma A/S (NASDAQ:ASND) also received a Moderate Buy consensus from eighteen firms, with one sell, sixteen buy, one strong buy; average 12‑month target $289.88.